Here, we demonstrated that in all five bladder cancer cell lines tested, Ad5/35 had a much higher transduction efficacy and cytotoxicity compared with Ad5; this likely reflects the more abundant expression of CD46 in these bladder cancer cells (Figure 4). Here, CD46 is linked to urinary bladder cancer.